Shuttle Pharmaceuticals Holdings, Inc.

Shuttle Pharmaceuticals acquired Molecule.ai, an AI platform for molecular discovery and early-stage drug development that uses machine learning algorithms to accelerate drug discovery iteration cycles while maintaining scientific reproducibility and traceability.